leisure time -WSS

leisure time

author：comprehensive 2025-09-29 01:38:45 - browse：2

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： A solution to the after

explore

WSS

Biogen shutters digital health group, ends Apple study, in cost cutting move

Community Health Systems hospitals under DOJ investigation

Listen: Who gets the credit for GLP

He's a Nobel laureate. Critics say he was misleading on Covid

Alabama frozen embryo ruling has major implications for IVF clinics

FDA advisers vote against ALS treatment from BrainStorm

leisure time

leisure time

knowledge

Supreme Court strikes down use of affirmative action

Medicare inequities exacerbate Puerto Rico’s health disparities

Apple is now the first public company to be valued at $3 trillion

FDA seeks to regulate lab

Dobbs anniversary: the lost opportunity of abortion as health care

The Harvard botanist who searched for psychedelics in the Amazon

Apple is now the first public company to be valued at $3 trillion

After a drawn out lobbying fight, ARPA

Malaria cases in Florida and Texas: Here’s what you need to know

Alabama IVF ruling threatens families facing fatal genetic disease

focus

Why do women spend more than men on medical expenses?

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

How one patient went off dialysis — and others can too

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

He's a Nobel laureate. Critics say he was misleading on Covid

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

hotspot

explore

leisure time

explore